Teladoc Q3 Revenue Down 2%, Shares Move Lower on Mixed Results

Teladoc Health reported Q3 revenue of $626.44 million, beating estimates. However, total revenue was down 2% YoY, and the company reported a loss of 20 cents per share, beating estimates. The company expects Q4 revenue of $622 million to $652 million and a loss of 10 to 25 cents per share. Teladoc narrowed its full-year 2025 guidance, expecting revenue of $2.51 billion to $2.54 billion and a loss of $1.10 to $1.25 per share. Shares were down 3.16% in after-hours trading.